Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Oral Cancer | Research

Factors associated with recurrence in patients with oral cancer in Mongolia

Authors: Oyuntsetseg Davaatsend, Munkhdul Altannamar, Mandukhai Ganbat, Urjinlkham Jagdagsuren

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Introduction

In Mongolia, there has been limited research on the posttreatment survival rate, recurrence, and occurrence of oral cancer. The goal of this study is to investigate the risk factors that contribute to the recurrence of oral cancer to increase survival rates, facilitate early detection, and improve treatment accuracy.

Method

A retrospective cohort method was used, with medical records from 173 patients diagnosed with squamous cell carcinoma of the mouth at the National Cancer Center of Mongolia’s Department of Head and Neck Surgery, Radio, and Chemotherapy between 2012 and 2017. The Mongolian National University of Medical Sciences’ Research Ethics Committee approved the project.

Results

The findings revealed that 109 cases (63.0%) were men and 64 (37.0%) were females, with a large proportion of patients (28.3%) falling between the ages of 61 and 70. Men had a 3.8 times higher risk of cancer recurrence than women (OR = 3.79, CI = 1.24–11.57). Furthermore, lymph node metastases and treatment were linked to oral cancer recurrence.

Conclusion

This study offers light on the factors that influence the recurrence of oral cancer, giving useful insights for improving patient outcomes through early detection and proper treatment.
Literature
1.
go back to reference Bagnardi V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580–93.CrossRefPubMed Bagnardi V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580–93.CrossRefPubMed
2.
go back to reference Han AY, et al. Epidemiology of squamous cell carcinoma of the lip in the United States: a Population-based cohort analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(12):1216–23.CrossRefPubMed Han AY, et al. Epidemiology of squamous cell carcinoma of the lip in the United States: a Population-based cohort analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(12):1216–23.CrossRefPubMed
4.
go back to reference Rastin M. Clinical & immunological characteristics in systemic lupus erythematosus patients. Indian J Med Res, 2017. 146. Rastin M. Clinical & immunological characteristics in systemic lupus erythematosus patients. Indian J Med Res, 2017. 146.
5.
go back to reference Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
6.
go back to reference Mohanta A, Mohanty P, Parida G. Human oral squamous cell carcinoma (OSCC) in Odisha: A hospital-based study 2013. 2013: p. 124–132. Mohanta A, Mohanty P, Parida G. Human oral squamous cell carcinoma (OSCC) in Odisha: A hospital-based study 2013. 2013: p. 124–132.
7.
go back to reference Sgaramella N, et al. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br J Cancer. 2015;113(2):321–6.CrossRefPubMedPubMedCentral Sgaramella N, et al. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br J Cancer. 2015;113(2):321–6.CrossRefPubMedPubMedCentral
8.
go back to reference Health NIo, editor. recurrence definition. NCI Dictionary of Cancer Terms 2023. Health NIo, editor. recurrence definition. NCI Dictionary of Cancer Terms 2023.
9.
go back to reference Dhanuthai K, et al. Oral cancer: a multicenter study. Med Oral Patol Oral Cir Bucal. 2018;23(1):e23–9.PubMed Dhanuthai K, et al. Oral cancer: a multicenter study. Med Oral Patol Oral Cir Bucal. 2018;23(1):e23–9.PubMed
10.
go back to reference Kruse Gujer A, Bredell M, Grätz K. Oral squamous cell carcinoma in non-smoking and non-drinking patients. Head Neck Oncol. 2010;2:24.CrossRef Kruse Gujer A, Bredell M, Grätz K. Oral squamous cell carcinoma in non-smoking and non-drinking patients. Head Neck Oncol. 2010;2:24.CrossRef
11.
go back to reference Riggauer J, et al. Risk factors for fear of recurrence in Head and Neck Cancer patients. Laryngoscope. 2023;133(7):1630–7.CrossRefPubMed Riggauer J, et al. Risk factors for fear of recurrence in Head and Neck Cancer patients. Laryngoscope. 2023;133(7):1630–7.CrossRefPubMed
12.
go back to reference Sood S, et al. Factors associated with recurrence in oral cavity squamous cell carcinoma: a real-world experience from an Indian comprehensive cancer center. J Clin Oncol. 2022;40(16suppl):e18018–18018.CrossRef Sood S, et al. Factors associated with recurrence in oral cavity squamous cell carcinoma: a real-world experience from an Indian comprehensive cancer center. J Clin Oncol. 2022;40(16suppl):e18018–18018.CrossRef
13.
go back to reference Szewczyk M et al. Prognostic factors Associated with successful salvage surgery in recurrent oral Cancer. Diagnostics (Basel), 2021. 11(6). Szewczyk M et al. Prognostic factors Associated with successful salvage surgery in recurrent oral Cancer. Diagnostics (Basel), 2021. 11(6).
14.
go back to reference Thavarool SB, et al. Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India. World J Surg Oncol. 2019;17(1):15.CrossRefPubMedPubMedCentral Thavarool SB, et al. Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India. World J Surg Oncol. 2019;17(1):15.CrossRefPubMedPubMedCentral
16.
go back to reference Wang W, et al. A study of epidemiologic and recurrence factors of oral Cancer. J Oral Maxillofac Surg. 2012;70(9):2205–10.CrossRefPubMed Wang W, et al. A study of epidemiologic and recurrence factors of oral Cancer. J Oral Maxillofac Surg. 2012;70(9):2205–10.CrossRefPubMed
17.
go back to reference Vázquez-Mahía I, et al. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg. 2012;70(7):1724–32.CrossRefPubMed Vázquez-Mahía I, et al. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg. 2012;70(7):1724–32.CrossRefPubMed
18.
go back to reference Hassan NH, et al. Risk factors associated with disease recurrence in patients with T4 staged squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. J Pak Med Assoc. 2022;72(12):2399–403.CrossRefPubMed Hassan NH, et al. Risk factors associated with disease recurrence in patients with T4 staged squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. J Pak Med Assoc. 2022;72(12):2399–403.CrossRefPubMed
19.
go back to reference Jones KR, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch Otolaryngol Head Neck Surg. 1992;118(5):483–5.CrossRefPubMed Jones KR, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch Otolaryngol Head Neck Surg. 1992;118(5):483–5.CrossRefPubMed
20.
go back to reference Noble AR, et al. Risk factors Associated with Disease recurrence in patients with stage III/IV squamous cell carcinoma of the oral cavity treated with surgery and postoperative Radiotherapy. Anticancer Res. 2016;36(2):785–92.PubMed Noble AR, et al. Risk factors Associated with Disease recurrence in patients with stage III/IV squamous cell carcinoma of the oral cavity treated with surgery and postoperative Radiotherapy. Anticancer Res. 2016;36(2):785–92.PubMed
21.
go back to reference Xie L, Shang Z. Burden of oral cancer in Asia from 1990 to 2019: estimates from the global burden of Disease 2019 study. PLoS ONE. 2022;17(3):e0265950.CrossRefPubMedPubMedCentral Xie L, Shang Z. Burden of oral cancer in Asia from 1990 to 2019: estimates from the global burden of Disease 2019 study. PLoS ONE. 2022;17(3):e0265950.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Alamgir MM, Jamal Q, Mirza T. Conventional clinical and prognostic variables in 150 oral squamous cell carcinoma cases from the indigenous population of Karachi. Pak J Med Sci. 2016;32(3):672–6.CrossRefPubMedPubMedCentral Alamgir MM, Jamal Q, Mirza T. Conventional clinical and prognostic variables in 150 oral squamous cell carcinoma cases from the indigenous population of Karachi. Pak J Med Sci. 2016;32(3):672–6.CrossRefPubMedPubMedCentral
24.
27.
go back to reference van Dijk BA, et al. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer. 2016;139(3):574–83.CrossRefPubMed van Dijk BA, et al. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer. 2016;139(3):574–83.CrossRefPubMed
28.
go back to reference Honorato J, et al. Gender differences in prognostic factors for oral cancer. Int J Oral Maxillofac Surg. 2015;44(10):1205–11.CrossRefPubMed Honorato J, et al. Gender differences in prognostic factors for oral cancer. Int J Oral Maxillofac Surg. 2015;44(10):1205–11.CrossRefPubMed
29.
go back to reference Antunes J, et al. Gender and racial inequalities in trends of oral cancer mortality in Sao Paulo, Brazil. Rev Saude Publica. 2013;47(3):470–8.CrossRefPubMed Antunes J, et al. Gender and racial inequalities in trends of oral cancer mortality in Sao Paulo, Brazil. Rev Saude Publica. 2013;47(3):470–8.CrossRefPubMed
30.
go back to reference Carman M. Women close the oral cancer gender gap. Todays FDA. 2012;24(2):18–21.PubMed Carman M. Women close the oral cancer gender gap. Todays FDA. 2012;24(2):18–21.PubMed
31.
go back to reference Chiang CT, et al. Elucidating the underlying causes of oral cancer through spatial clustering in high-risk areas of Taiwan with a distinct gender ratio of incidence. Geospat Health. 2010;4(2):230–42.CrossRefPubMed Chiang CT, et al. Elucidating the underlying causes of oral cancer through spatial clustering in high-risk areas of Taiwan with a distinct gender ratio of incidence. Geospat Health. 2010;4(2):230–42.CrossRefPubMed
32.
go back to reference Zavras AI, et al. Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece. Oral Oncol. 2001;37(1):28–35.CrossRefPubMed Zavras AI, et al. Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece. Oral Oncol. 2001;37(1):28–35.CrossRefPubMed
33.
go back to reference Zini A, et al. Trends of oral and pharyngeal cancer in Israel, by gender, age, ethnic group, and country of origin: 1970–2006. Community Dent Oral Epidemiol. 2009;37(6):547–54.CrossRefPubMed Zini A, et al. Trends of oral and pharyngeal cancer in Israel, by gender, age, ethnic group, and country of origin: 1970–2006. Community Dent Oral Epidemiol. 2009;37(6):547–54.CrossRefPubMed
Metadata
Title
Factors associated with recurrence in patients with oral cancer in Mongolia
Authors
Oyuntsetseg Davaatsend
Munkhdul Altannamar
Mandukhai Ganbat
Urjinlkham Jagdagsuren
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12118-8

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine